Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bradley N Mills

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|August 20, 2017
Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell NicheBradley N Mills, George P Albert, Marc W Halterman
Journal of Cellular Biochemistry|April 27, 2017
PGE2 Receptor Subtype 1 (EP1) Regulates Mesenchymal Stromal Cell Osteogenic Differentiation by Modulating Cellular Energy MetabolismMarina Feigenson, Roman A Eliseev, Jennifer H Jonason, et al.
ACS Omega|March 27, 2023
Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum <i>A Posteriori</i> Probability (MAP) EstimationDebamitra Chakraborty, Bradley N Mills, Jing Cheng, et al.
Sensors (Basel, Switzerland)|April 13, 2024
High-Density Polyethylene Custom Focusing Lenses for High-Resolution Transient Terahertz Biomedical Imaging SensorsDebamitra Chakraborty, Robert Boni, Bradley N Mills, et al.
Stem Cells and Development|October 22, 2015
Energy Metabolism in Mesenchymal Stem Cells During Osteogenic DifferentiationLaura C Shum, Noelle S White, Bradley N Mills, et al.
Cancer Immunology Research|November 14, 2019
Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic CancerJian Ye, Bradley N Mills, Tony Zhao, et al.
Immunological Investigations|June 6, 2020
Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal AdenocarcinomaBooyeon J Han, Joseph D Murphy, Shuyang Qin, et al.
Journal for Immunotherapy of Cancer|July 19, 2022
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancerJian Ye, Bradley N Mills, Shuyang S Qin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body RadiotherapyBradley N Mills, Haoming Qiu, Michael G Drage, et al.
Cancers|January 25, 2025
Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC ModelsJian Ye, Shuyang S Qin, Angela L Hughson, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|August 20, 2017
Expression Profiling of the MAP Kinase Phosphatase Family Reveals a Role for DUSP1 in the Glioblastoma Stem Cell NicheBradley N Mills, George P Albert, Marc W Halterman
Journal of Cellular Biochemistry|April 27, 2017
PGE2 Receptor Subtype 1 (EP1) Regulates Mesenchymal Stromal Cell Osteogenic Differentiation by Modulating Cellular Energy MetabolismMarina Feigenson, Roman A Eliseev, Jennifer H Jonason, et al.
ACS Omega|March 27, 2023
Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum <i>A Posteriori</i> Probability (MAP) EstimationDebamitra Chakraborty, Bradley N Mills, Jing Cheng, et al.
Sensors (Basel, Switzerland)|April 13, 2024
High-Density Polyethylene Custom Focusing Lenses for High-Resolution Transient Terahertz Biomedical Imaging SensorsDebamitra Chakraborty, Robert Boni, Bradley N Mills, et al.
Stem Cells and Development|October 22, 2015
Energy Metabolism in Mesenchymal Stem Cells During Osteogenic DifferentiationLaura C Shum, Noelle S White, Bradley N Mills, et al.
Cancer Immunology Research|November 14, 2019
Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic CancerJian Ye, Bradley N Mills, Tony Zhao, et al.
Immunological Investigations|June 6, 2020
Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal AdenocarcinomaBooyeon J Han, Joseph D Murphy, Shuyang Qin, et al.
Journal for Immunotherapy of Cancer|July 19, 2022
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancerJian Ye, Bradley N Mills, Shuyang S Qin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body RadiotherapyBradley N Mills, Haoming Qiu, Michael G Drage, et al.
Cancers|January 25, 2025
Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC ModelsJian Ye, Shuyang S Qin, Angela L Hughson, et al.
Pageof 2